trial enrollment - Robuta Search

https://www.adventhealth.com/institutes/research/news/adventhealth-leads-nation-star-trial-enrollment AdventHealth Leads the Nation in STAR Trial Enrollment | AdventHealth Research Institute AdventHealth Research Institute (AHRI) is proud to be the highest enrolling site in the United States for the STAR trial. the nation trial enrollment adventhealth leads star https://www.techtarget.com/pharmalifesciences/news/366607132/Pfizer-Completes-Trial-Enrollment-for-Lyme-Disease-Vaccine Pfizer Completes Trial Enrollment for Lyme Disease Vaccine | TechTarget Pfizer completes Phase 2 trial enrollment for its Lyme disease vaccine candidate, with 625 patients ranging in age from five to 65 years of age. lyme disease vaccine trial enrollment pfizer completes techtarget https://www.sas.com/en_gb/software/clinical-enrollment-simulation.html SAS Clinical Trial Enrollment Simulation | SAS UK SAS Clinical Enrollment Trial Simulation is a solution that uses powerful discrete event simulation to devise better projections for enrollment planning. clinical trial enrollment sas simulation uk https://gethealthkey.com/ Boost Clinical Trial Enrollment - HealthKey HealthKey is an AI-powered Patient Identification service for Clinical Trial Sites. We help identify and qualify patients fast by matching trials' eligibility... clinical trial enrollment boost https://www.techtarget.com/pharmalifesciences/news/366606733/Decentralization-Tools-May-Improve-Cancer-Clinical-Trial-Enrollment Decentralization Tools May Improve Cancer Clinical Trial Enrollment | TechTarget A recent investigation concluded that decentralizing clinical trials using remote technology and additional tools may help improve cancer clinical trial... clinical trial enrollment decentralization tools may improve https://www.bostonscientific.com/en-US/products/stents--coronary/bioabsorbable-polymer-stent/EVOLVE-Short-DAPT-enrollment-complete.html EVOLVE Short DAPT Trial Enrollment Complete - Boston Scientific Boston Scientific has invested in short DAPT clinical trials designed to study various patient populations commonly treated by physicians. Prof. Ian Meredith,... trial enrollment evolve short dapt complete https://www.businesswire.com/news/home/20260107085136/en/Cairn-Surgical-Announces-Completion-of-Enrollment-in-U.S.-Pivotal-Trial-of-Novel-Breast-Cancer-Locator-System Cairn Surgical Announces Completion of Enrollment in U.S. Pivotal Trial of Novel Breast Cancer... Cairn Surgical completes enrollment in its U.S. pivotal trial of the Breast Cancer Locator System designed to improve the precision of tumor removal. https://www.prnewswire.com/news-releases/orthotrophix-announces-early-completion-of-enrollment-in-phase-2b-trial-of-tpx-100-in-knee-osteoarthritis-302695405.html OrthoTrophix Announces Early Completion of Enrollment in Phase 2b Trial of TPX-100 in Knee... /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company developing novel investigational therapies for osteoarthritis, today announced... https://www.prnewswire.co.uk/news-releases/dipexium-announces-completion-of-enrollment-objective-in-onestep-1-pivotal-phase-3-clinical-trial-579624801.html Dipexium Announces Completion of Enrollment Objective in OneStep-1 Pivotal Phase 3 Clinical Trial /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of... https://www.biospace.com/otonomy-inc-completes-enrollment-in-phase-ii-clinical-trial-for-auripro-in-pediatric-patients-with-acute-otitis-media-with-tympanostomy-tubes Otonomy, Inc. Completes Enrollment In Phase II Clinical Trial For Auripro In Pediatric Patients... https://finviz.com/news/202055/gt-biopharma-provides-enrollment-update-on-gtb-3650-phase-1-trial-in-patients-with-relapsed-or-refractory-rr-cd33-expressing-hematologic-malignancies GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or... Stock screener for investors and traders, financial visualizations. https://www.biospace.com/press-releases/keros-therapeutics-announces-update-on-enrollment-in-the-phase-2-tropos-trial Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial - BioSpace https://www.prnewswire.com/news-releases/the-usher-syndrome-coalition-announces-partnership-with-proqr-to-support-clinical-trial-enrollment-for-a-potential-therapy-for-ush2a-mediated-retinitis-pigmentosa-301470693.html The Usher Syndrome Coalition announces partnership with ProQR to support clinical trial enrollment... /PRNewswire/ -- For more than ten years, the Usher Syndrome Coalition has been working to build its international "USH Trust" registry in anticipation of the... https://www.barchart.com/story/news/35755720/avalo-therapeutics-announces-completion-of-enrollment-in-phase-2-lotus-trial-of-avtx-009-for-the-treatment-of-hidradenitis-suppurativa Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the... WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing... https://www.takeda.com/newsroom/newsreleases/2016/takeda-and-zinfandel-pharmaceuticals-complete-enrollment-in-tommorrow-trial/ Takeda and Zinfandel Pharmaceuticals Complete Enrollment in TOMMORROW Trial Takeda and Zinfandel Pharmaceuticals Complete Enrollment in TOMMORROW Trial takeda zinfandel pharmaceuticals complete enrollment https://investingnews.com/zelda-therapeutics-completes-enrollment-for-latest-clinical-trial Zelda Therapeutics Completes Enrollment for Latest Clinical Trial | INN Jan 2, 2026 - Zelda Therapeutics (ASX:ZLD,OTCQB:ZLDAF) informed the market its clinical trial for medical cannabis treating insomnia completed its enrollment. As quoted in... clinical trial zelda therapeutics completes enrollment https://www.biospace.com/aegea-medical-completes-enrollment-in-the-pace-ii-clinical-trial AEGEA Medical Completes Enrollment in the Pace II Clinical Trial - BioSpace Jan 8, 2019 - Study is assessing uterine cavity access and projected intervention feasibility three to four years post endometrial vapor ablation for heavy menstrual bleeding in the clinical trial aegea medical completes https://www.businesswire.com/news/home/20260121338054/en/Concept-Medical-Announces-First-Patient-Enrollment-in-STARS-DAPT-Randomized-Clinical-Trial-Evaluating-Abluminus-NP-Polymer-Free-DES Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial... Concept Medical Inc. is proud to announce the successful enrollment of the first patients in the STARS DAPT randomized controlled trial. concept medical patient enrollment https://www.biospace.com/capricor-therapeutics-inc-completes-enrollment-of-phase-ii-clinical-trial-for-cenderitide-to-treat-heart-failure Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To... https://www.biospace.com/press-releases/nektar-therapeutics-announces-completion-of-target-enrollment-in-rezolve-ad-phase-2b-clinical-trial-of-rezpegaldesleukin-in-patients-with-moderate-to-severe-atopic-dermatitis Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial... https://finviz.com/news/172096/medicinova-announces-completion-of-patient-enrollment-in-combat-als-phase-2b3-clinical-trial-of-mn-166-ibudilast MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of... Stock screener for investors and traders, financial visualizations. https://www.sciencemediacentre.org/expert-reaction-to-remap-cap-trial-collaboration-pausing-enrollment-of-critically-ill-covid-19-patients-into-the-anticoagulants-trial/ expert reaction to REMAP-CAP trial collaboration pausing enrollment of critically ill COVID-19... https://www.news-medical.net/news/20150305/Asterias-begins-enrollment-for-AST-OPC1-Phase-12a-trial-to-treat-complete-cervical-spinal-cord-injury.aspx Asterias begins enrollment for AST-OPC1 Phase 1/2a trial to treat complete cervical spinal cord... Mar 5, 2015 - Asterias Biotherapeutics, Inc., a leading biotechnology company in the emerging field of regenerative medicine, announced today that Atlanta-based Shepherd... https://investingnews.com/daily/life-science-investing/biotech-investing/ocugen-completes-50-percent-enrollment-in-phase-3-clinical-trial/ Ocugen Completes 50 Percent Enrollment in Phase 3 Clinical Trial | INN Jan 2, 2026 - Ocugen (NASDAQ:OCGN) has announced it has completed 50 percent of patient enrollment in its Phase 3 clinical trial of OCU300 for patients with ocular Graft... clinical trial completes percent enrollment https://www.biospace.com/cervomed-announces-completion-of-enrollment-in-phase-2b-rewind-lb-clinical-trial-of-neflamapimod-for-the-treatment-of-patients-with-dementia-with-lewy-bodies CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod... Jun 12, 2024 - CervoMed Inc., a clinical stage company focused on developing treatments for age-related neurologic disorders, announced that it has completed enrollment in... https://www.businesswire.com/news/home/20250402441311/en/Turn-Therapeutics-Launches-Final-Crowdfund-Round-Ahead-of-Eczema-Trial-Enrollment-Engages-Clear-Street-to-Explore-Public-Markets Turn Therapeutics Launches Final Crowdfund Round Ahead of Eczema Trial Enrollment, Engages Clear... Turn Therapeutics launched its final crowdfund investment round, ahead of a clinical trial for the use of its topical therapy in patients with eczema. https://www.biospace.com/penwest-pharmaceutical-completes-patient-enrollment-of-phase-iia-trial-for-pw4142 Penwest Pharmaceutical Completes Patient Enrollment Of Phase IIa Trial For PW4142 - BioSpace patient enrollment https://finviz.com/news/251366/ideaya-biosciences-completes-targeted-full-enrollment-in-randomized-pivotal-phase-23-trial-optimum-02-of-darovasertib-in-combination-with-crizotinib-in-first-line-hlaa2-negative-metastatic-uveal-melanoma IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial... Stock screener for investors and traders, financial visualizations. https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-initiation-of-enrollment-to-the-phase-2a-clinical-trial-of-per001-intravitreal-implant-in-diabetic-retinopathy-301892514.html?tc=eml_cleartime Perfuse Therapeutics Announces Initiation of Enrollment to the Phase 2A Clinical Trial of PER001... /PRNewswire/ -- Perfuse Therapeutics, a biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases is pleased... https://www.prweb.com/releases/dia_2014_50th_annual_meeting_panel_to_explore_clinical_trial_enrollment_obstacles/prweb11850099.htm DIA 2014 50th Annual Meeting Panel to Explore Clinical Trial Enrollment Obstacles Washington (PRWEB) May 13, 2014 -- Experts dedicated to enhancing clinical trials will explore hurdles in patient enrollment at the DIA 2014 50th Annual... clinical trial enrollment annual meeting https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2019.00104/full Frontiers | The Impact of an Educational Video on Clinical Trial Enrollment and Knowledge in Ethnic... Introduction: Innovative methods to increase awareness about clinical trials and address barriers associated with low participation among racial/ethnic minor...